Botulinum toxin for the treatment of strabismus

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 3, 2017, Pages

  Rowe, Fiona J ^a   Noonan, Carmel P ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; HYALURONIC ACID; BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

CONJUNCTIVAL HEMORRHAGE; DIPLOPIA; DRUG EFFICACY; EYE SURGERY; HUMAN; MEDLINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PTOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; STEREOSCOPIC VISION; STRABISMUS; SYSTEMATIC REVIEW; ABDUCENS NERVE DISEASES; ADULT; BINOCULAR VISION; CHILD; META ANALYSIS;

ABDUCENS NERVE DISEASES; ADULT; BOTULINUM TOXINS, TYPE A; CHILD; HUMANS; NEUROMUSCULAR AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STRABISMUS; VISION, BINOCULAR;

EID: 85014393726     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006499.pub4     Document Type: Review

References (48)

1. Carruthers JD, Kennedy RA, Bagaric D. Botulinum versus adjustable suture surgery in the treatment of horizontal misalignment in adult patients lacking fusion. Archives of Ophthalmology 1990;108(10):1432-5. 2785181
2. Chen J, Deng D, Zhong H, Lin X, Kang Y, Wu H, et al. Botulinum toxin injections combined with or without sodium hyaluronate in the absence of electromyography for the treatment of infantile esotropia: a pilot study. Eye 2013;27(3):382-6. 2785183
3. Lee J, Harris S, Cohen J, Cooper K, MacEwen C, Jones S. Results of a prospective randomized trial of botulinum toxin therapy in acute unilateral sixth nerve palsy. Journal of Pediatric Ophthalmology & Strabismus 1994;31(5):283-6. 2785185
4. Minguini N, de Carvalho KM, Bosso FLS, Hirato FE, Kara-José N. Surgery with intraoperative botulinum toxin-A injection for the treatment of large-angle horizontal strabismus: a pilot study. Clinics 2012;67(3):279-82. 2785187
5. Tejedor J, Rodríguez JM. Retreatment of children after surgery for acquired esotropia: reoperation versus botulinum toxin. British Journal of Ophthalmology 1998;82(2):110-4. 2785189
6. Tejedor J, Rodríguez JM. Early retreatment of infantile esotropia: comparison of reoperation and botulinum toxin. British Journal of Ophthalmology 1999;83(7):783-7. 2785191
7. Cooper K, Lee JP, MacEwen C, Jones S. Botulinum toxin A injection for acute sixth nerve palsy. Transactions of the 8th International Orthoptic Congress. 1991; Vol. VIII:336-40. 2785193
8. de Alba Campomanes AG, Binenbaum G, Campomanes Eguiarte G. Comparison of botulinum toxin with surgery as primary treatment for infantile esotropia. Journal of AAPOS 2010;14(2):111-6. 2785195
9. de Alba Campomanes AG, Binenbaum G, Eguiarte GC. Comparison of botulinum toxin to surgery as primary treatment for infantile esotropia. Journal of AAPOS 2009;13(1):e4. 2785196
10. Etezad Razavi M, Sharifi M, Armanfar F. Efficacy of botulinum toxin in the treatment of intermittent exotropia. Strabismus 2014;22(4):176-81. 2785198
11. Gursoy H, Basmak H, Sahin A, Yildirim N, Aydin Y, Colak E. Long-term follow-up of bilateral botulinum toxin injections versus bilateral recessions of the medial rectus muscles for treatment of infantile esotropia. Journal of AAPOS 2012;16(3):269-73. 2785200
12. Li Y, Wu X. [Observation of botulinum toxin A management in childhood with intermittent exotropia]. Zhonghua Yan Ke Za Zhi [Chinese Journal of Ophthalmology] 2008;44(11):967-71. 2785202
13. Mills MD, Coats DK, Donahue SP, Wheeler DT, American Academy of Ophthamology. Strabismus surgery for adults. Ophthalmology 2004;111(6):1255-62. 2785204
14. Sanjari MS, Falavarjani KG, Kashkouli MB, Aghai GH, Nojomi M, Rostami H. Botulinum toxin injection with and without electromyographic assistance for treatment of abducens nerve palsy: a pilot study. Journal of AAPOS 2008;12(3):259-62. 2785206
15. Shallo-Hoffman J, Acheson J, Bentley C, Bronstein AM. The influence of adaptation of visual motion detection in chronic sixth nerve palsy after treatment with botulinum toxin. Strabismus 2006;14(3):129-35. 2785208
16. Jain S, Anand S, Jones A. Intraoperative botulinum toxin in large angle strabismus. Journal of AAPOS 2015;19(4):e12. 5290165
17. PACTR201508001241218 . Botulinum neurotoxin as first line therapy in the management of childhood esotropia. www.pactr.org/ (accessed 23 April 2016). 5290167
18. Adams RJ, Hall HL, Courage ML. Long-term visual pathology in children with significant perinatal complications. Developmental Medicine and Child Neurology 2005;47(9):598-602.
19. Bunting HJ, Dawson EL, Lee JP, Adams GG. Role of inferior rectus botulinum toxin injection in vertical strabismus resulting from orbital pathology. Strabismus 2013;21(3):165-8.
20. Campos EC, Schiavi C, Bellusci C. Critical age of botulinum toxin treatment in essential infantile esotropia. Journal of Pediatric Ophthalmology and Strabismus 2000;37(6):328-32.
21. Crouch ER. Use of botulinum toxin in strabismus. Current Opinion in Ophthalmology 2006;17(5):435-40.
22. Dawson EL, Marshman WE, Adams GG. The role of botulinum toxin A in acute-onset esotropia. Ophthalmology 1999;106(9):1727-30.
23. Dawson EL, Sainari A, Lee JP. Does botulinum toxin have a role in the treatment of secondary strabismus?. Transactions of the 29th European Strabismological Association; 2004 June 1-4; Izmir, Turkey. 2004:53-4.
24. Dawson EL, Lee JP. Does botulinum toxin have a role in the treatment of small-angle esotropia?. Strabismus 2004;12(4):257-60.
25. Dawson EL, Sainani A, Lee JP. Does botulinum toxin have a role in the treatment of secondary strabismus?. Strabismus 2005;13(2):71-3.
26. Dawson E, Ali N, Lee JP. Botulinum toxin injection into the superior rectus for treatment of strabismus. Strabismus 2012;20(1):24-5.
27. Donnelly UM, Stewart NM, Hollinger M. Prevalence and outcomes of childhood visual disorders. Ophthalmic Epidemiology 2005;12(4):243-50.
28. Gardner R, Dawson EL, Adams GG, Lee JP. The use of botulinum toxin to treat strabismus following retinal detachment surgery. Strabismus 2013;21(1):8-12.
29. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
30. GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 14 May 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
31. Higgins JP, Altman DG, Sterne JAC editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
32. Holmes JM, Leske DA, Christiansen SP. Initial treatment outcomes in chronic sixth nerve palsy. Journal of AAPOS 2001;5(6):370-6.
33. Kerr NC, Hoehn MB. Botulinum toxin for sixth nerve palsies in children with brain tumors. Journal of AAPOS 2001;5(1):21-5.
34. Langendam MW, AKL EA, Dahm P, Glasziou P, Guyatt G, Schünemann HJ. Assessing and presenting summaries of evidence in Cochrane reviews. Systematic Reviews 2013;2:81.
35. Marsh IB. Botulinum toxin and the eye. Hospital Medicine 2003;64(8):464-7.
36. McNeer KW, Tucker MG, Guerry CH, Spencer RF. Incidence of stereopsis after treatment of infantile esotropia with botulinum toxin A. Journal of Pediatric Ophthalmology and Strabismus 2003;40(5):288-92.
37. Ozkan SB, Topalolu A, Aydin S. The role of botulinum toxin A in augmentation of the effect of recession and/or resection surgery. Journal of AAPOS 2006;10(2):124-7.
38. Rayner SA, Hollick EJ, Lee JP. Botulinum toxin in childhood strabismus. Strabismus 1999;7(2):103-11.
39. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
40. Rowe F, Noonan C, Nayak H. Use of botulinum toxin in pre-adolescent children. Transactions of the 10th International Orthoptic Congress; 2004 Nov 14-17; Melbourne. 2004; CD-ROM 187704024x.
41. Rowe FJ, Noonan CP, Nayak H. Botulinum toxin as a treatment option for decompensating intermittent strabismus in children. Transactions of the 30th European Strabismological Association; 2005 June 8-11; Killarney, Ireland. 2005:101-4.
42. Sabetti L, D'Alessandri L, Salvatori K, Balestrazzi E. The use of botulinum toxin type A in the treatment of chronic sixth ocular nerve palsy. Transactions of the 28th European Strabismological Association; 2003 June 19-21; Bergen. 2003:191-2.
43. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980;87(10):1044-9.
44. Spencer RF, Tucker MG, Choi RY, McNeer KW. Botulinum toxin management of childhood intermittent exotropia. Ophthalmology 1997;104(11):1762-7.
45. Strömland K, Miller MT. Thalidomide embryopathy: revisited 27 years later. Acta Ophthalmologica 1993;71(2):238-45.
46. Tejedor J, Rodríguez JM. Long-term outcome and predictor variables in the treatment of acquired esotropia with botulinum toxin. Investigative Ophthalmology and Visual Science 2001;42(11):2542-6.
47. Rowe FJ, Noonan CP. Botulinum toxin for the treatment of strabismus. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD006499.pub2]
48. Rowe FJ, Noonan CP. Botulinum toxin for the treatment of strabismus. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD006499.pub3]